GlassScriptPhysician profile
Cathy J Halperin
NPI 1275620734
$2,964.64
in general payments reported to CMS, 2019-2025
28 companies · $497 in 2025
The $497 reported for 2025 was more than what 80% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $390 · 2020: $34.55 · 2021: $214 · 2022: $485 · 2023: $796 · 2024: $549 · 2025: $497.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,757 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,756.93 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $400.97 | 2022-2025 | |
| Hologic Sales and Service, LLC | $393.82 | 2023-2025 | Myosure Tissue Removal Device, Acessa Provu System |
| Sumitomo Pharma America, INC. | $383.36 | 2023-2025 | Myfembree |
| Gynesonics, INC. | $284.77 | 2022-2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Pfizer INC. | $197.44 | 2019-2025 | |
| Astellas Pharma US INC | $196.57 | 2024-2025 | Veozah |
| Coopersurgical, INC. | $109.46 | 2019-2025 | Paragard T 380a |
| Abbvie INC. | $105.85 | 2019-2021 | |
| Myovant Sciences INC. | $98.41 | 2021-2022 | |
| Roche Diagnostics Corporation | $85.02 | 2019-2020 | |
| Daiichi Sankyo INC. | $72.72 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $66.82 | 2019-2023 | |
| Intuitive Surgical, INC. | $66.66 | 2024 | |
| Baxter Healthcare | $65.16 | 2025 | Perclot |
| Amag Pharmaceuticals, INC. | $44.43 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $43.79 | 2021 | |
| Ethicon US, LLC | $43.35 | 2023 | Mega Soft, Surgiflo Hemostatic Matrix |
| Biogen, INC. | $42.03 | 2025 | Zurzuvae |
| Merck Sharp & Dohme LLC | $35.40 | 2019-2020 | |
| Exeltis, USA INC. | $35.33 | 2022-2025 | Slynd |
| Therapeuticsmd, INC. | $33.59 | 2019-2022 | |
| Aspira Women'S Health INC | $32.63 | 2022 | |
| Mylan Pharmaceuticals INC. | $31.13 | 2022 | |
| Boston Scientific Corporation | $29.65 | 2025 | Axonics |
| Exact Sciences Corporation | $24.59 | 2024 | Cologuard Collection Kit |
| Scynexis, INC. | $15.44 | 2022 | |
| Avion Pharmaceuticals | $14.30 | 2022 | |
| Channel Medsystems, INC. | $11.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cathy Halperin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.